secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001193125-22-270961
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q1 FY23 revenue $950.3M (+5% YoY, +9% CC); GAAP EPS $1.43, non-GAAP $1.51
--------------------------------------------------------------------------------

- Revenue $950.3M, up 5% YoY (9% constant currency); Americas (ex-SaaS) revenue up 18%.
- GAAP operating profit $275.7M (+5%), non-GAAP operating profit $290.8M (+4%).
- GAAP diluted EPS $1.43 vs $1.39; non-GAAP diluted EPS $1.51 flat YoY.
- Board declared quarterly dividend $0.44/share, payable Dec 15, 2022, record Nov 10.
- Acquired mementor (German digital sleep medicine); opened new R&D facility in Ireland.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522270961/0001193125-22-270961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522270961/d416189d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-270961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer